Invention Grant
- Patent Title: Lanthionine synthetase C-like 2-based therapeutics
-
Application No.: US16653446Application Date: 2019-10-15
-
Publication No.: US10682349B2Publication Date: 2020-06-16
- Inventor: Josep Bassaganya-Riera , Adria Carbo Barrios , Richard Gandour , Julian D. Cooper , Raquel Hontecillas
- Applicant: Landos Biopharma, Inc.
- Applicant Address: US VA Blacksburg
- Assignee: LANDOS BIOPHARMA, INC.
- Current Assignee: LANDOS BIOPHARMA, INC.
- Current Assignee Address: US VA Blacksburg
- Agency: DeWitt LLP
- Agent Daniel A. Blasiole
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D403/12 ; C07D413/12 ; C07D413/14 ; A61K31/496 ; C07D213/69 ; C07D307/60 ; C07C65/40 ; C07D213/79 ; C07D307/68 ; C07D403/14 ; A61K31/4184 ; A61K31/423 ; A61K31/4439
Abstract:
Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
Public/Granted literature
- US20200046694A1 LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS Public/Granted day:2020-02-13
Information query
